Cargando…
CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells
The generation of tissue-specific cell types from human embryonic stem cells (hESCs) is critical for the development of future stem cell-based regenerative therapies. Here, we identify CD13 and ROR2 as cell-surface markers capable of selecting early cardiac mesoderm emerging during hESC differentiat...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720015/ https://www.ncbi.nlm.nih.gov/pubmed/26771355 http://dx.doi.org/10.1016/j.stemcr.2015.11.006 |
_version_ | 1782411024318595072 |
---|---|
author | Skelton, Rhys J.P. Brady, Bevin Khoja, Suhail Sahoo, Debashis Engel, James Arasaratnam, Deevina Saleh, Kholoud K. Abilez, Oscar J. Zhao, Peng Stanley, Edouard G. Elefanty, Andrew G. Kwon, Murray Elliott, David A. Ardehali, Reza |
author_facet | Skelton, Rhys J.P. Brady, Bevin Khoja, Suhail Sahoo, Debashis Engel, James Arasaratnam, Deevina Saleh, Kholoud K. Abilez, Oscar J. Zhao, Peng Stanley, Edouard G. Elefanty, Andrew G. Kwon, Murray Elliott, David A. Ardehali, Reza |
author_sort | Skelton, Rhys J.P. |
collection | PubMed |
description | The generation of tissue-specific cell types from human embryonic stem cells (hESCs) is critical for the development of future stem cell-based regenerative therapies. Here, we identify CD13 and ROR2 as cell-surface markers capable of selecting early cardiac mesoderm emerging during hESC differentiation. We demonstrate that the CD13+/ROR2+ population encompasses pre-cardiac mesoderm, which efficiently differentiates to all major cardiovascular lineages. We determined the engraftment potential of CD13+/ROR2+ in small (murine) and large (porcine) animal models, and demonstrated that CD13+/ROR2+ progenitors have the capacity to differentiate toward cardiomyocytes, fibroblasts, smooth muscle, and endothelial cells in vivo. Collectively, our data show that CD13 and ROR2 identify a cardiac lineage precursor pool that is capable of successful engraftment into the porcine heart. These markers represent valuable tools for further dissection of early human cardiac differentiation, and will enable a detailed assessment of human pluripotent stem cell-derived cardiac lineage cells for potential clinical applications. |
format | Online Article Text |
id | pubmed-4720015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-47200152016-02-22 CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells Skelton, Rhys J.P. Brady, Bevin Khoja, Suhail Sahoo, Debashis Engel, James Arasaratnam, Deevina Saleh, Kholoud K. Abilez, Oscar J. Zhao, Peng Stanley, Edouard G. Elefanty, Andrew G. Kwon, Murray Elliott, David A. Ardehali, Reza Stem Cell Reports Article The generation of tissue-specific cell types from human embryonic stem cells (hESCs) is critical for the development of future stem cell-based regenerative therapies. Here, we identify CD13 and ROR2 as cell-surface markers capable of selecting early cardiac mesoderm emerging during hESC differentiation. We demonstrate that the CD13+/ROR2+ population encompasses pre-cardiac mesoderm, which efficiently differentiates to all major cardiovascular lineages. We determined the engraftment potential of CD13+/ROR2+ in small (murine) and large (porcine) animal models, and demonstrated that CD13+/ROR2+ progenitors have the capacity to differentiate toward cardiomyocytes, fibroblasts, smooth muscle, and endothelial cells in vivo. Collectively, our data show that CD13 and ROR2 identify a cardiac lineage precursor pool that is capable of successful engraftment into the porcine heart. These markers represent valuable tools for further dissection of early human cardiac differentiation, and will enable a detailed assessment of human pluripotent stem cell-derived cardiac lineage cells for potential clinical applications. Elsevier 2016-01-12 /pmc/articles/PMC4720015/ /pubmed/26771355 http://dx.doi.org/10.1016/j.stemcr.2015.11.006 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Skelton, Rhys J.P. Brady, Bevin Khoja, Suhail Sahoo, Debashis Engel, James Arasaratnam, Deevina Saleh, Kholoud K. Abilez, Oscar J. Zhao, Peng Stanley, Edouard G. Elefanty, Andrew G. Kwon, Murray Elliott, David A. Ardehali, Reza CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title | CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title_full | CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title_fullStr | CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title_full_unstemmed | CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title_short | CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells |
title_sort | cd13 and ror2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720015/ https://www.ncbi.nlm.nih.gov/pubmed/26771355 http://dx.doi.org/10.1016/j.stemcr.2015.11.006 |
work_keys_str_mv | AT skeltonrhysjp cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT bradybevin cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT khojasuhail cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT sahoodebashis cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT engeljames cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT arasaratnamdeevina cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT salehkholoudk cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT abilezoscarj cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT zhaopeng cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT stanleyedouardg cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT elefantyandrewg cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT kwonmurray cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT elliottdavida cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells AT ardehalireza cd13andror2permitisolationofhighlyenrichedcardiacmesodermfromdifferentiatinghumanembryonicstemcells |